EUA
TRIPLEX CII-SARS-CoV-2 rRT-PCR TEST
FDA Emergency Use Authorization · Columbia University Laboratory of Personalized Genomic Medicine · Sep 14, 2020
Key facts
| Product | TRIPLEX CII-SARS-CoV-2 rRT-PCR TEST |
|---|---|
| Company | Columbia University Laboratory of Personalized Genomic Medicine |
| Date | Sep 14, 2020 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: